Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine May/22/2021 48 0
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine May/22/2021 12 1
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/08/2021 22 0
Glycyrrhizic acid Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 5 0
mAb2 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/24/2021 1 0
mAb8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/24/2021 1 0
ZF2001 Potential treatment - clinical evidence Experimental Vaccine Mar/24/2021 1 0
Ginkgolide M Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
Mezerein Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
Tubocurarine Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0